These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28122677)

  • 1. Colistin- and carbapenem-resistant Klebsiella oxytoca harboring bla
    Simon M; Melzl H; Hiergeist A; Richert K; Falgenhauer L; Pfeifer Y; Gerlach RG; Fuchs K; Reischl U; Gessner A; Jantsch J
    Int J Med Microbiol; 2017 Feb; 307(2):113-115. PubMed ID: 28122677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca.
    Jayol A; Poirel L; Villegas MV; Nordmann P
    Int J Antimicrob Agents; 2015 Jul; 46(1):108-10. PubMed ID: 25982250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.
    Chen LR; Zhou HW; Cai JC; Zhang R; Chen GX
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):163-7. PubMed ID: 19748427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of an IncA/C plasmid encoding VIM-4 and CMY-4 β-lactamases in Klebsiella oxytoca and Citrobacter koseri from an inpatient in a cardiac rehabilitation unit.
    Caltagirone M; Bitar I; Piazza A; Spalla M; Nucleo E; Navarra A; Migliavacca R
    New Microbiol; 2015 Jul; 38(3):387-92. PubMed ID: 26147151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
    Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
    Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colistin-resistant KPC-2-producing Klebsiella pneumoniae ST423 harboring an IS5-like element in the mgrB gene isolated from cerebrospinal fluid.
    da Silva HRF; Vilela MA; Almeida ACS; de Morais MMC
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):184-185. PubMed ID: 29540262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator.
    Cannatelli A; D'Andrea MM; Giani T; Di Pilato V; Arena F; Ambretti S; Gaibani P; Rossolini GM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5521-6. PubMed ID: 23979739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread of Carbapenem and Colistin-Resistant Klebsiella pneumoniae ST512 Clinical Isolates in Israel: A Cause for Vigilance.
    Lalaoui R; Bakour S; Livnat K; Assous MV; Diene SM; Rolain JM
    Microb Drug Resist; 2019; 25(1):63-71. PubMed ID: 30129868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae in Tunisia.
    Mansour W; Haenni M; Saras E; Grami R; Mani Y; Ben Haj Khalifa A; El Atrouss S; Kheder M; Fekih Hassen M; Boujâafar N; Bouallegue O; Madec JY
    J Glob Antimicrob Resist; 2017 Sep; 10():88-94. PubMed ID: 28711559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States.
    Mediavilla JR; Patrawalla A; Chen L; Chavda KD; Mathema B; Vinnard C; Dever LL; Kreiswirth BN
    mBio; 2016 Aug; 7(4):. PubMed ID: 27578755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
    Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
    Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids.
    Giordano C; Barnini S; Tsioutis C; Chlebowicz MA; Scoulica EV; Gikas A; Rossen JW; Friedrich AW; Bathoorn E
    Int J Antimicrob Agents; 2018 Feb; 51(2):260-265. PubMed ID: 29097338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae Mediated by Chromosomal Integration of Plasmid DNA.
    Cienfuegos-Gallet AV; Chen L; Kreiswirth BN; Jiménez JN
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole genome sequencing for the molecular characterization of carbapenem-resistant Klebsiella pneumoniae strains isolated at the Italian ASST Fatebenefratelli Sacco Hospital, 2012-2014.
    Rimoldi SG; Gentile B; Pagani C; Di Gregorio A; Anselmo A; Palozzi AM; Fortunato A; Pittiglio V; Ridolfo AL; Gismondo MR; Rizzardini G; Lista F
    BMC Infect Dis; 2017 Oct; 17(1):666. PubMed ID: 29017452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin- and Carbapenem-Resistant Klebsiella pneumoniae Clinical_Isolates: Algeria.
    Yousfi H; Hadjadj L; Dandachi I; Lalaoui R; Merah A; Amoura K; Dahi A; Dekhil M; Messalhi N; Diene SM; Baron S; Rolain JM
    Microb Drug Resist; 2019 Mar; 25(2):258-263. PubMed ID: 30256174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
    Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interruption of mgrB in the mediation of colistin resistance in Klebsiella oxytoca.
    Olaitan AO; Rolain JM
    Int J Antimicrob Agents; 2015 Sep; 46(3):354-5. PubMed ID: 26126797
    [No Abstract]   [Full Text] [Related]  

  • 18. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae.
    Poirel L; Jayol A; Bontron S; Villegas MV; Ozdamar M; Türkoglu S; Nordmann P
    J Antimicrob Chemother; 2015 Jan; 70(1):75-80. PubMed ID: 25190723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of metallo-β-lactamase genes in clinically isolated Klebsiella pneumoniae and Klebsiella oxytoca.
    Tateno H; Yasuhara T; Sugano E; Tahara S; Ugajin K; Fukuchi K
    Rinsho Byori; 2014 Dec; 62(12):1191-6. PubMed ID: 25823233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.